N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide

C57H66N6O9 — CID 101167585

IUPACN-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide
SMILESCC(C)(C)c1cc2c(OCC(=O)Nc3cccnc3)c(c1)COCc1cc(C(C)(C)C)cc(c1OCC(=O)Nc1cccnc1)COCc1cc(C(C)(C)C)cc(c1OCC(=O)Nc1cccnc1)COC2
InChIInChI=1S/C57H66N6O9/c1-55(2,3)43-19-37-28-67-30-39-21-44(56(4,5)6)23-41(53(39)71-35-50(65)62-47-14-11-17-59-26-47)32-69-33-42-24-45(57(7,8)9)22-40(54(42)72-36-51(66)63-48-15-12-18-60-27-48)31-68-29-38(20-43)52(37)70-34-49(64)61-46-13-10-16-58-25-46/h10-27H,28-36H2,1-9H3,(H,61,64)(H,62,65)(H,63,66)
InChIKeyNUUYHEUMRZQXNL-UHFFFAOYSA-N
MW979.19 g/mol
LogP10.28
Rot. Bonds12

About N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide

N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide (PubChem CID 101167585) has the molecular formula C57H66N6O9 and a molecular weight of 979.19 g/mol. Its IUPAC name is N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide.

Molecular Properties

Compound NameN-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide
PubChem CID101167585
Molecular FormulaC57H66N6O9
Molecular Weight979.19 g/mol
Exact Mass978.49
IUPAC NameN-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide
SMILESCC(C)(C)c1cc2c(OCC(=O)Nc3cccnc3)c(c1)COCc1cc(C(C)(C)C)cc(c1OCC(=O)Nc1cccnc1)COCc1cc(C(C)(C)C)cc(c1OCC(=O)Nc1cccnc1)COC2
InChIInChI=1S/C57H66N6O9/c1-55(2,3)43-19-37-28-67-30-39-21-44(56(4,5)6)23-41(53(39)71-35-50(65)62-47-14-11-17-59-26-47)32-69-33-42-24-45(57(7,8)9)22-40(54(42)72-36-51(66)63-48-15-12-18-60-27-48)31-68-29-38(20-43)52(37)70-34-49(64)61-46-13-10-16-58-25-46/h10-27H,28-36H2,1-9H3,(H,61,64)(H,62,65)(H,63,66)
InChIKeyNUUYHEUMRZQXNL-UHFFFAOYSA-N
XLogP10.28
TPSA181.35 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500979.19
LogP ≤ 510.28
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Analyze N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide?
The IUPAC name of N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide (CID 101167585) is N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide.
What is the SMILES notation for N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide?
The canonical SMILES for N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide is CC(C)(C)c1cc2c(OCC(=O)Nc3cccnc3)c(c1)COCc1cc(C(C)(C)C)cc(c1OCC(=O)Nc1cccnc1)COCc1cc(C(C)(C)C)cc(c1OCC(=O)Nc1cccnc1)COC2.
What is the InChIKey of N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide?
The InChIKey is NUUYHEUMRZQXNL-UHFFFAOYSA-N. The full InChI is InChI=1S/C57H66N6O9/c1-55(2,3)43-19-37-28-67-30-39-21-44(56(4,5)6)23-41(53(39)71-35-50(65)62-47-14-11-17-59-26-47)32-69-33-42-24-45(57(7,8)9)22-40(54(42)72-36-51(66)63-48-15-12-18-60-27-48)31-68-29-38(20-43)52(37)70-34-49(64)61-46-13-10-16-58-25-46/h10-27H,28-36H2,1-9H3,(H,61,64)(H,62,65)(H,63,66).
What are the key properties of N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide?
N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide has a molecular weight of 979.19 g/mol, XLogP of 10.28, 12 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-pyridin-3-yl-2-[[7,15,23-tritert-butyl-26,27-bis[2-oxo-2-(pyridin-3-ylamino)ethoxy]-3,11,19-trioxatetracyclo[19.3.1.15,9.113,17]heptacosa-1(24),5,7,9(27),13(26),14,16,21(25),22-nonaen-25-yl]oxy]acetamide is sourced from PubChem (CID 101167585), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).